Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07307040

Precision Diabetes Management: Integrated East-West Approach

This project will leverage a large-scale cohort of early-onset type 2 diabetes patients to conduct innovative prospective clinical research. By integrating traditional Chinese medicine diagnostic information, clinical data, laboratory results, continuous glucose monitoring, genetic information, multi-omics data, and multi-modal monitoring data, and utilizing advanced data analysis methods such as deep learning, the project aims to establish a comprehensive monitoring, precise classification, and personalized diagnosis and treatment model-a holistic management approach integrating traditional Chinese and Western medicine for early-onset type 2 diabetes. This initiative is expected to enhance the management of early-onset type 2 diabetes, improve treatment outcomes and quality of life for affected patients, pioneer an innovative path for personalized integrated traditional Chinese and Western medicine management in this population, and promote the application of precision medicine in diabetes prevention and treatment.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Early-Onset Type 2 Diabetes

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The age at diabetes diagnosis is ≥18 years but <40 years.

Exclusion criteria

  • The clinical diagnosis was type 1 diabetes, and at the time of enrollment, antibody levels or insulin/C-peptide results still supported the original diagnosis.

There were clear secondary factors contributing to hyperglycemia, such as Cushing's syndrome or pheochromocytoma.

Treatment and study plan

No interventions

Other

No interventions

Primary outcomes

  1. Traditional Chinese Medicine Syndrome Score

    Time frame: Through study completion, an average of 3 months

  2. HbA1c

    Time frame: Through study completion, an average of 3 months

Secondary outcomes

  1. Triglycerides

    Time frame: Through study completion, an average of 3 months

  2. High-Density Lipoprotein Cholesterol

    Time frame: Through study completion, an average of 3 months

  3. Total Cholesterol

    Time frame: Through study completion, an average of 3 months

  4. Fasting Blood Glucose

    Time frame: Through study completion, an average of 3 months

  5. Low-Density Lipoprotein Cholesterol

    Time frame: Through study completion, an average of 3 months

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Registry information

Official study title

Construction of a Precision and Individualized Management Model for Diabetes With Integrated Traditional Chinese and Western Medicine

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Dec 29, 2025
Registry last updated
Dec 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.